gpt-dict.com

乳香（印度乳香） Boswellia serrata × 骨關節炎

結論：證據支持但有警示

膝關節炎確實存在多篇 RCT 與 meta-analysis 一致顯示標準化乳香酸萃取物（AKBA）顯著改善疼痛與功能，效果量大，方向一致，這是草本抗炎成分中證據基礎相對紮實者。

B 🟡 B 初步證據 附警語發布 🚨 high — heavy affiliate marketing in TW community
⚠️ 標記 ⚠️ COI（產業聯盟資助） 🧪 反證據已標記 🇹🇼 台灣在地警示 💊 檢驗 / 藥物交互作用

膝關節炎確實存在多篇 RCT 與 meta-analysis 一致顯示標準化乳香酸萃取物（AKBA）顯著改善疼痛與功能，效果量大，方向一致，這是草本抗炎成分中證據基礎相對紮實者。

但無法評為 A 以上：絕大多數正向 RCT 由 Sami-Sabinsa、Sundyota Numandis 等產業資助（高 COI），效果量異常龐大（WOMAC 改善 68-74%）疑有報導偏差；療效高度綁定特定標準化專利萃取物（Aflapin、Boswellin Super、5-Loxin），與一般乳香樹脂不可等同；且無任何主要醫學會（ACR、OARSI）正式背書。

綜合證據強度與系統性偏差後評為 B（中度／混合 RCT 證據）。

⚖️

評分透明度

所有分數由 7 層證據引擎計算，過程公開可查
原始分數 0.61
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
B · 附警語發布
信心度
70%
證據方向大致一致
證據層級
E2
多篇高品質統合分析（≥2 篇一致）

各層「支持此療效」的程度

分數越低＝該層越不支持
L5 臨床機構權威立場
0.44
L1 Examine國際基準
0.50
L3 機轉生理合理性
0.65
L11 AI 複核獨立判讀
0.65
L2 PubMed原始文獻
0.85
不支持 中性 / 混合 支持
▸查看完整決策路徑（audit trail）
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.611
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (2 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標，未降階
  5. detect_disputes — 偵測到 0 個 hard + 1 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-an
PMID: 32680575 2020 統合分析 n = 545
結論：Boswellia significantly reduced VAS pain (WMD -8.33, p<0.00001), WOMAC pain (WMD -14.22, p=0.0006), stiffness (WMD -10.04, p=0.0007), function (WMD -10.75, p<0.00001), and Lequesne index (WMD -2.27, p<0.00001) vs control.
效應量：WMD VAS -8.33; WMD WOMAC pain -14.22
前往 PubMed
Efficacy evaluation of standardized Boswellia serrata extract (Aflapin®) in osteoarthritis: A systematic review
PMID: 38365549 2024 統合分析 n = 712
結論：Aflapin® showed superior VAS reduction vs other BS extracts (-16.09 vs -4.68) and WOMAC pain (-18.68 vs -7.07); all p<0.0001 across 9 RCTs.
⚠️ 廠商資助 效應量：VAS WMD -16.09 (Aflapin) vs -4.68 (other BS); WOMAC pain WMD -18.68 vs -7.07
前往 PubMed
A standardized Boswellia serrata extract shows improvements in knee osteoarthritis within five days - a double-
PMID: 39092235 2024 RCT (double-blind) n = 105
結論：By day 90: VAS pain reduced 45.3% (150 mg) and 61.9% (300 mg); WOMAC total improved 68.5% and 73.6% respectively; inflammatory markers decreased significantly; improvements detectable within 5 days.
⚠️ 廠商資助 效應量：VAS reduction 45-62%; WOMAC total 68-74% improvement from baseline
前往 PubMed
Clinical Benefits of Boswellia Serrata (BOSMAX®) in Early Knee Osteoarthritis: A Randomized, Placebo-Controlled
PMID: 41220252 2025 RCT (double-blind) n = 150
結論：WOMAC decreased -24.55 at day 90 (p<0.05); Lequesne index improved -4.53; VAS reduced significantly at days 60 and 90; TNF-α decreased -104.75 ng/L (p<0.05).
效應量：WOMAC MD -24.55; Lequesne MD -4.53 at 90 days
前往 PubMed
Evaluating the efficacy and safety of Curcuma longa, Boswellia serrata, and their mixed formulation in treating
PMID: 41082950 2025 統合分析 n = 1,633
結論：Modified Boswellia serrata formulations showed significant improvement in WOMAC pain, stiffness, and knee function vs other groups; no significant safety differences across comparisons.
效應量：null
前往 PubMed
A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswelli
PMID: 30838706 2019 RCT (double-blind) n = 48
結論：BSE significantly improved physical function, pain, and stiffness vs placebo; improved radiographic knee joint spacing; hs-CRP reduced significantly (p<0.01).
🟠 品質有限 ⚠️ 廠商資助 效應量：p<0.01 for inflammatory markers; pain/function p-values not fully reported in abstract
前往 PubMed

L4a US FDA
謹慎
FLAVORING AGENT OR ADJUVANT 來源↗
L4b EU EFSA
反對
L4c UK NHS
未表態
— 本適應症無對應資料
L4d TW TFDA / 衛福部
謹慎
易誤用中藥材 乳香（Olibanum）— 乳香為橄欖科植物卡氏乳香樹（Boswellia carterii Birdw.）及同屬數種植物皮部滲出的油膠樹脂。列入食藥署「誤用中藥材目錄」第55項（公告日期2010-01-05）。 來源↗
L4e WHO
支持
Gummi Boswellii (the gum-resin from Boswellia species) is included in WHO Monographs on Selected Medicinal Plants, Volume 4 (2009), pages 48–60, covering uses supported by clinical data, uses described in pharmacopoeias and traditional systems of medicine, and uses described in folk medicine. 來源↗

L5a NIH Office of Dietary Supplements
謹慎
L5b Mayo Clinic
謹慎
boswellia, also known as Indian frankincense extract, contains boswellic acid which acts as an anti-inflammatory, and participants in two clinical trials reported noticeable pain relief within about a week of taking daily doses of specific Indian frankincense extracts 來源↗
L5c Cleveland Clinic
未表態
— 本適應症無對應資料
L5d Harvard Health
中性
L5e Specialty Society (condition-mapped)
謹慎

PTT · Dcard · Mobile01 彙整自公開論壇討論，非統計抽樣，僅反映社群風向。
廣告 / 業配密度 極高
低中高
📍立場總覽

PTT（Pharmacy/regimen/FITNESS）、Dcard、Mobile01 的關節保健討論幾乎只圍繞葡萄糖胺、軟骨素、UC-II、MSM、綠唇貝、薑黃與膠原蛋白，找不到台灣鄉民針對「乳香／印度乳香」用於骨關節炎的實測心得；既有的「乳香」討論多屬芳療精油情境，或為保健品廠商（啟動生技、芙姵爾生醫、BRAXX）與 SEO 部落格的業配內容，並非匿名社群真實經驗。

💬社群實感

無共識（台灣社群幾乎無相關實測討論）

L10a · 廠商行銷話術 行銷語言
💬 通路如何宣傳

NOW Foods 乳香萃取 250mg NT$707

代表來源 ↗
L10b · TFDA 法定身份 官方認定

易誤用中藥材 乳香（Olibanum）

來源 ↗

  • 陸上運動與肌力訓練
  • 減重（過重者）
  • 局部或口服 NSAID
✓ PMID 100% 反查全部經 NCBI Entrez 驗證
🔬 6 篇 L2 文獻 經多層 sub-agent 獨立評估
🇹🇼 含台灣社群分析L10c PTT / Dcard / Mobile01
aggregated_at: 2026-06-01 claim_version: v25 engine_version: v1.0 claim_id: CLM-COND-osteoarthritis-INT-boswellia-001
查看 ClaimReview 結構化資料 (JSON-LD) 
{
  "@context": "https://schema.org",
  "@type": "ClaimReview",
  "url": "https://gpt-dict.com/claim/CLM-COND-osteoarthritis-INT-boswellia-001/",
  "datePublished": "2026-06-01",
  "author": {
    "@type": "Organization",
    "name": "gpt-dict.com",
    "url": "https://gpt-dict.com"
  },
  "claimReviewed": "乳香（印度乳香）能改善骨關節炎",
  "inLanguage": "zh-TW",
  "itemReviewed": {
    "@type": "Claim",
    "appearance": []
  },
  "reviewRating": {
    "@type": "Rating",
    "ratingValue": 3,
    "bestRating": 5,
    "worstRating": 1,
    "alternateName": "🟡 B 初步證據"
  }
}